Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-2,405
Closed -$209K 481
2020
Q4
$209K Sell
2,405
-160
-6% -$13.8K 0.01% 461
2020
Q3
$230K Buy
2,565
+20
+0.8% +$1.93K 0.01% 403
2020
Q2
$265K Buy
+2,545
New +$245K 0.01% 372
2020
Q1
Sell
-2,400
Closed -$210K 445
2019
Q4
$210K Buy
+2,400
New +$205K 0.01% 461
2019
Q3
Sell
-2,370
Closed -$201K 500
2019
Q2
$201K Sell
2,370
-350
-13% -$28.1K 0.01% 480
2019
Q1
$234K Buy
+2,720
New +$221K 0.01% 483
2018
Q3
Sell
-3,290
Closed -$220K 583
2018
Q2
$220K Hold
3,290
0.01% 544
2018
Q1
$274K Buy
3,290
+180
+6% +$16.2K 0.01% 509
2017
Q4
$295K Buy
3,110
+1,060
+52% +$111K 0.01% 508
2017
Q3
$239K Buy
2,050
+320
+18% +$40.5K 0.01% 544
2017
Q2
$218K Buy
+1,730
New +$220K 0.01% 563

Other funds holding INCY

Conning Inc's INCY Position: Q1 2021 in Review

Conning Inc sold out of Incyte (INCY) in Q1 2021, closing a stake of 2,405 shares — an estimated $209K sold.

Conning Inc first reported a position in INCY in Q2 2017 and held it in 11 quarters. The position peaked at $295K in Q4 2017. 493 funds tracked by Wall St. Rank hold INCY as of Q1 2021.

  • Conning Inc reported no remaining Incyte position as of Q1 2021 after selling out during the quarter.
  • Conning Inc sold 2,405 Incyte shares in Q1 2021, an estimated $209K.
  • Conning Inc first reported a position in Incyte in Q2 2017 and held it in 11 quarters.
  • Conning Inc's Incyte position peaked at $295K in Q4 2017.
  • 493 funds tracked by Wall St. Rank held Incyte as of Q1 2021.

Based on Conning Inc's 13F filing for Q1 2021, filed 23 Apr 2021.